207 related articles for article (PubMed ID: 3872056)
1. Electrophysiologic and antiarrhythmic properties of bepridil.
Prystowsky EN
Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
Rowland E; McKenna WJ; Krikler DM
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867
[TBL] [Abstract][Full Text] [Related]
3. Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.
Singh BN; Nademanee K; Feld G; Piontek M; Schwab M
Am J Cardiol; 1985 Mar; 55(7):14C-19C. PubMed ID: 3872052
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of QT interval and antiarrhythmic action of bepridil.
Somberg J; Torres V; Flowers D; Miura D; Butler B; Gottlieb S
Am Heart J; 1985 Jan; 109(1):19-27. PubMed ID: 3871296
[TBL] [Abstract][Full Text] [Related]
5. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
Keren G; Tepper D; Butler B; Torres V; Somberg JC
Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
[TBL] [Abstract][Full Text] [Related]
6. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R
Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516
[TBL] [Abstract][Full Text] [Related]
7. [Bepridil--electrophysiologic properties of a new calcium antagonist with an anti-arrhythmia effect].
Zehender M; Geibel A; Henning B; Hohnloser S; Meinertz T; Just H
Z Kardiol; 1988 Feb; 77(2):93-8. PubMed ID: 3259053
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
[TBL] [Abstract][Full Text] [Related]
9. [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
Vester EG
Herz; 1997 Jun; 22 Suppl 1():40-50. PubMed ID: 9333591
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
Sung RJ; Juma Z; Saksena S
Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
[TBL] [Abstract][Full Text] [Related]
12. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
Gomes JA; Hariman RJ; Kang PS; Chowdry IH
J Am Coll Cardiol; 1985 Jan; 5(1):45-57. PubMed ID: 3964808
[TBL] [Abstract][Full Text] [Related]
13. Use of calcium channel entry blockers in the treatment of cardiac arrhythmias.
Akhtar M; Tchou P; Jazayeri M
Circulation; 1989 Dec; 80(6 Suppl):IV31-9. PubMed ID: 2688983
[TBL] [Abstract][Full Text] [Related]
14. [Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study].
Lévy S; Metge M; Cointe R; Labrunie P; Valeix P; Gérard R
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():63-6. PubMed ID: 3938261
[TBL] [Abstract][Full Text] [Related]
15. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic and antiarrhythmic effects of carocainide in humans.
Bach P; Steinbeck G
J Cardiovasc Pharmacol; 1988 Dec; 12(6):637-42. PubMed ID: 2467080
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics.
Ohe T; Shimomura K; Aihara N; Kamakura S; Matsuhisa M; Sato I; Nakagawa H; Shimizu A
Circulation; 1988 Mar; 77(3):560-8. PubMed ID: 3342487
[TBL] [Abstract][Full Text] [Related]
18. The prophylaxis of AV nodal re-entry tachycardia.
Tonkin AM; Shorne L
Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473
[TBL] [Abstract][Full Text] [Related]
19. Intravenous dantrolene does not exhibit calcium channel blocking effects on the cardiac conduction system in humans.
Kentsch M; Roewer N; Kunze KP; Kuck KH
Anesthesiology; 1991 Oct; 75(4):583-7. PubMed ID: 1928768
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias.
Roy D; Montigny M; Klein GJ; Sharma AD; Cassidy D
Am J Cardiol; 1987 Jan; 59(1):89-92. PubMed ID: 3492906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
